PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA.\', \'Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, USA.\', \'Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, USA; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, USA; Department of Microbiology and Immunology, UNC School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0169-409X(20)30277-510.1016/j.addr.2020.12.006
?:doi
?:hasPublicationType
?:journal
  • Advanced drug delivery reviews
is ?:pmid of
?:pmid
?:pmid
  • 33316346
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.09
?:rankingScore_hIndex
  • 261
is ?:relation_isRelatedTo_publication of
?:title
  • Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33316346>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33316346>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all